i saw this article the other day -
those with thyroid issue might be interested as well
http://dailyreckoning.com/a-natural-eli ... t-ails-ya/
As we age, NF-kappaB calls in more and more false alarms until we are in a state of chronic low-level inflammation. Eventually, this chronic
inflammation tends to localize at some point of vulnerability until we have a health-threatening disease that ends our lives prematurely.
For this reason, a substance that would calm down NF-kappaB activation without suppressing legitimate immune system function has been called the “holy grail” of modern medicine. To make a long story short, that Holy Grail has been found in members of the solanaceous plant family, which includes eggplant, peppers and tobacco.
In fact, this alkaloid was discovered while searching for an effective smoking cessation aid. Researchers have long known that there’s more than nicotine in tobacco that leads smokers to smoke. This was obvious due to fact that smoking has powerful and pleasurable calming effects, via MAO inhibition, that nicotine does not provide. Moreover, despite the clear dangers of smoking, the tobacco plant has known medicinal values.
Rather, I’m telling you to watch for final data from three major studies under way now. The Roskamp Institute, a leading brain disease research center, is doing the Alzheimer’s trials. Roskamp, directed by two of the scientists who discovered the amyloid connection to Alzheimer’s, Drs. Michael Mullan and Fiona Crawford, has also overseen an interventional study in Flint, Mich. Dr. Paul Ladenson, with colleagues from Johns Hopkins, is following up an animal study of thyroiditis with a human study.
Preliminary results from the Flint study have been released, revealing that the active ingredient in Anatabloc, at much lower doses than I take, reduced C-reactive protein (CRP) levels in 61% of diabetic patients. CRPs are associated with the onset and severity of diabetes and other diseases. These patients, in fact, all had other diseases and extremely high CRPs, so results are far more significant than they may appear.
The Hopkins thyroid study results should be completed in December, but we already know that the human studies are providing statistically significant results. If they are similar to the animal studies, which provided the first-ever improvements in thyroid disease, we will be able to reach extremely important scientifically validated conclusions.
In fact, positive results from all three ongoing studies would confirm the thesis that anatabine citrate does not treat specific diseases directly. Rather, it dramatically reduces the NF-kappaB-induced inflammation that affects all diseases. If this is true, and I’m personally convinced that it is, it means that we will be able to delay or prevent most of the conditions that prematurely shorten life.
), Alzheimer's, Parkinson's, and other dementia-associated diseases.
.
